Index of reports
> Cases with Multiple Myeloma (89)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Velcade (Bortezomib) where reactions include multiple myeloma. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 89 Next >>
Possible Velcade side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Hyperkalaemia, Interstitial Lung Disease, Multiple Myeloma
Adverse event resulted in: death
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Dexamethasone; Methylprednisolone Sodium Succinate; Glucose
Possible Velcade side effects in
Reported by a physician from United Kingdom on 2012-08-10
Patient:
Reactions: Diarrhoea, Drug Ineffective, Multiple Myeloma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Decadron
Dosage: 160 mg, qm
Administration route: Oral
Start date: 2010-10-18
End date: 2010-11-09
Decadron
Dosage: 160 mg, qm
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Doxorubicin Hydrochloride
Dosage: 64 mg, qd
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin Hydrochloride
Dosage: 64 mg, qm
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Velcade
Dosage: 2.4 mg/m2, on day 1, 4, 8, 11
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Velcade
Dosage: 2.4 mg/m2, on day 1, 4, 8, 11
Start date: 2010-10-18
End date: 2010-11-09
Other drugs received by patient: Gabapentin; Amoxicillin; Furosemide; Acetaminophen; Furosemide; Enoxaparin Sodium
Possible Velcade side effects in male
Reported by a pharmacist from United States on 2012-08-03
Patient: male
Reactions: Renal Failure, Anaemia, Encephalopathy, Multiple Myeloma, Hypercalcaemia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Multiple Myeloma
Decadron Phosphate
Indication: Multiple Myeloma
Revlimid
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-10-02
Velcade
Indication: Multiple Myeloma
Other drugs received by patient: Hydrocodone Bitartrate; Vitamins NOS; Prochlorperazine; Tamsulosin HCL; Venlafaxine; Aspirin; Miralax; Ibuprofen (Advil); Magnesium Oxide; Omeprazole; Oxycontin; Trazodone Hydrochloride; Finasteride
Possible Velcade side effects in 55 year old male
Reported by a physician from United Kingdom on 2012-08-02
Patient: 55 year old male, weighing 71.4 kg (157.1 pounds)
Reactions: Diarrhoea, Drug Ineffective, Multiple Myeloma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Decadron Phosphate
Dosage: 160 mg, qmo
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Decadron Phosphate
Dosage: 160 mg, qmo
Administration route: Oral
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin Hydrochloride
Dosage: 64 mg/h, qmo
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Doxorubicin Hydrochloride
Dosage: 64 mg, qmo
Start date: 2010-10-18
End date: 2010-11-09
Velcade
Start date: 2010-10-18
End date: 2010-11-10
Velcade
Indication: Multiple Myeloma
Start date: 2010-09-27
Other drugs received by patient: Gabapentin; Acetaminophen; Amoxicillin; Enoxaparin Sodium; Furosemide
Possible Velcade side effects in
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-01
Patient:
Reactions: Diarrhoea, Drug Ineffective, Multiple Myeloma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Decadron
Dosage: 160 mg, qm
Administration route: Oral
Start date: 2010-10-18
End date: 2010-11-09
Decadron
Dosage: 160 mg, qm
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Doxorubicin Hydrochloride
Dosage: 64 mg, qm
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Doxorubicin Hydrochloride
Dosage: 64 mg, qd
Start date: 2010-10-18
End date: 2010-11-09
Velcade
Dosage: 2.4 mg/m2, qd
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Velcade
Dosage: 2.4 mg/m2, qd
Start date: 2010-10-18
End date: 2010-11-09
Other drugs received by patient: Enoxaparin Sodium; Gabapentin; Acetaminophen; Amoxicillin; Furosemide; Furosemide
Possible Velcade side effects in
Reported by a physician from Japan on 2012-07-30
Patient:
Reactions: Renal Impairment, Hepatic Function Abnormal, Multiple Myeloma
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Prednisolone; Melphalan Hydrochloride
Possible Velcade side effects in
Reported by a consumer/non-health professional from United Kingdom on 2012-07-19
Patient:
Reactions: Drug Ineffective, Diarrhoea, Multiple Myeloma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Decadron
Dosage: 160 mg, qm
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Decadron
Dosage: 160 mg, qm
Administration route: Oral
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin HCL
Dosage: 64 mg, qd
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin HCL
Dosage: 64 mg, qm
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Velcade
Dosage: 2.4 mg/m2, qd
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Velcade
Dosage: 2.4 mg/m2, qd
Start date: 2010-10-18
End date: 2010-11-09
Other drugs received by patient: Amoxicillin; Furosemide; Furosemide; Enoxaparin Sodium; Acetaminophen; Gabapentin
Possible Velcade side effects in
Reported by a physician from Japan on 2012-07-16
Patient:
Reactions: Hepatic Function Abnormal, Renal Impairment, Multiple Myeloma
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Prednisolone; Melphalan Hydrochloride
Possible Velcade side effects in 55 year old male
Reported by a physician from United Kingdom on 2012-07-16
Patient: 55 year old male, weighing 71.4 kg (157.1 pounds)
Reactions: Drug Ineffective, Diarrhoea, Multiple Myeloma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 160 mg, qmo
Administration route: Oral
Start date: 2010-10-18
End date: 2010-11-09
Dexamethasone
Dosage: 160 mg, qmo
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Doxorubicin HCL
Dosage: 64 mg, qmo
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin HCL
Dosage: 64 mg/h, qmo
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Velcade
Start date: 2010-10-18
End date: 2010-11-10
Velcade
Indication: Multiple Myeloma
Start date: 2010-09-27
Other drugs received by patient: Amoxicillin; Gabapentin; Acetaminophen; Furosemide; Enoxaparin Sodium
Possible Velcade side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13
Patient: male, weighing 83.9 kg (184.6 pounds)
Reactions: Duodenitis, Multi-Organ Failure, Abdominal Pain, Oesophagitis, Sepsis, Anaemia, Multiple Myeloma, Hypertension, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Hydrocodone Bitartrate + Acetaminophen; Multi-Vitamins; Ranitidine; Decadron; Aspirin; Naproxen; Nifedipine
Possible Velcade side effects in
Reported by a individual with unspecified qualification from United Kingdom on 2012-07-13
Patient:
Reactions: Diarrhoea, Multiple Myeloma
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 160 mg, unk
Administration route: Oral
Start date: 2010-10-18
End date: 2010-11-09
Dexamethasone
Dosage: 160 mg, unk
Administration route: Oral
Indication: Prophylaxis
Start date: 2010-09-27
End date: 2010-10-17
Doxorubicin HCL
Dosage: 64 mg, unknown
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin HCL
Dosage: 64 mg, unknown
Indication: Polyuria
Start date: 2010-09-27
End date: 2010-10-17
Velcade
Dosage: 2.4 mg/m2, unknown
Indication: Anti-Infective Therapy
Start date: 2010-09-27
Velcade
Dosage: 2.4 mg/m2, unknown
Start date: 2010-10-18
End date: 2010-11-09
Other drugs received by patient: Acetaminophen; MK-0805; Gabapentin; Amoxicillin; MK-0805; Enoxaparin Sodium; Bebetina
Possible Velcade side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-06
Patient: 55 year old male
Reactions: Diarrhoea, Drug Ineffective, Multiple Myeloma
Drug(s) suspected as cause:
Dexamethasone Sodium Phosphate
Administration route: Oral
Start date: 2010-09-27
End date: 2010-10-17
Dexamethasone Sodium Phosphate
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin HCL
Indication: Multiple Myeloma
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin HCL
Start date: 2010-09-27
End date: 2010-10-17
Velcade
Dosage: dose unit:unknown
Start date: 2010-09-27
Velcade
Dosage: dose unit:unknown
Indication: Multiple Myeloma
Start date: 2010-10-18
End date: 2010-11-10
Other drugs received by patient: Gabapentin; Acetaminophen; Melphalan Hydrochloride; Thalidomide; Furosemide; Dexamethasone Sodium Phosphate; Furosemide; Cyclophosphamide; Amoxicillin; Cyclophosphamide; Enoxaparin Sodium
Possible Velcade side effects in
Reported by a physician from Germany on 2012-07-06
Patient:
Reactions: Neoplasm Malignant, Myelodysplastic Syndrome, Multiple Myeloma
Adverse event resulted in: death
Drug(s) suspected as cause:
Lenalidomide
Indication: Myelodysplastic Syndrome
Lenalidomide
Indication: Multiple Myeloma
Melphalan Hydrochloride
Dosage: 200 mg/m2, cyclic
Indication: Multiple Myeloma
Melphalan Hydrochloride
Indication: Myelodysplastic Syndrome
Thalidomide
Indication: Myelodysplastic Syndrome
Thalidomide
Indication: Multiple Myeloma
Velcade
Indication: Multiple Myeloma
Velcade
Indication: Myelodysplastic Syndrome
Possible Velcade side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-04
Patient: 55 year old male
Reactions: Drug Ineffective, Diarrhoea, Multiple Myeloma
Drug(s) suspected as cause:
Dexamethasone Sodium Phosphate
Administration route: Oral
Start date: 2010-09-27
End date: 2010-10-17
Dexamethasone Sodium Phosphate
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin HCL
Start date: 2010-09-27
End date: 2010-10-17
Doxorubicin HCL
Indication: Multiple Myeloma
Start date: 2010-10-18
End date: 2010-11-09
Velcade
Dosage: dose unit:unknown
Start date: 2010-09-27
Velcade
Dosage: dose unit:unknown
Indication: Multiple Myeloma
Start date: 2010-10-18
End date: 2010-11-10
Other drugs received by patient: Enoxaparin Sodium; Amoxicillin; Dexamethasone Sodium Phosphate; Melphalan Hydrochloride; Cyclophosphamide; Thalidomide; Gabapentin; Acetaminophen
Possible Velcade side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-03
Patient: 55 year old male, weighing 71.4 kg (157.1 pounds)
Reactions: Diarrhoea, Drug Ineffective, Multiple Myeloma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone Sodium Phosphate
Dosage: 160 mg, qmo
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Dexamethasone Sodium Phosphate
Dosage: 160 mg, qmo
Administration route: Oral
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin HCL
Dosage: 64 mg/h, qmo
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Doxorubicin HCL
Dosage: 64 mg, qmo
Start date: 2010-10-18
End date: 2010-11-10
Velcade
Start date: 2010-10-18
End date: 2010-11-10
Velcade
Indication: Multiple Myeloma
Start date: 2010-09-27
Other drugs received by patient: Gabapentin; Furosemide; Amoxicillin; Enoxaparin Sodium; Acetaminophen
Possible Velcade side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-03
Patient: 55 year old male
Reactions: Diarrhoea, Neoplasm Progression, Multiple Myeloma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 160 mg; ;po
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Dexamethasone
Dosage: 160 mg; ;po
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin HCL
Dosage: 64 mg; iv
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Doxorubicin HCL
Dosage: 64 mg; iv
Indication: Multiple Myeloma
Start date: 2010-10-10
End date: 2010-11-09
Velcade
Dosage: 2.4 mg/m2; ;iv
Indication: Multiple Myeloma
Start date: 2010-09-27
Velcade
Dosage: 2.4 mg/m2; ;iv
Indication: Multiple Myeloma
Start date: 2010-10-18
End date: 2010-11-09
Other drugs received by patient: Amoxicillin; Gabapentin; Furosemide; Acetaminophen; Enoxaparin Sodium; Furosemide
Possible Velcade side effects in
Reported by a physician from Spain on 2012-06-29
Patient:
Reactions: Death, Acute Febrile Neutrophilic Dermatosis, Multiple Myeloma
Adverse event resulted in: death
Drug(s) suspected as cause:
Prednisone
Dosage: 0.5 mg/kg, qd
Indication: Prophylaxis
Velcade
Indication: Multiple Myeloma
Other drugs received by patient: Enalapril Maleate; Prednisone
Possible Velcade side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29
Patient: male, weighing 128.1 kg (281.8 pounds)
Reactions: Musculoskeletal Pain, Anaemia, Mental Status Changes, Multiple Myeloma, Hypercalcaemia, Osteonecrosis, Fatigue, Gait Disturbance, Thrombocytopenia, Pathological Fracture
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Cytoxan
Dexamethasone
Indication: Product Used FOR Unknown Indication
Etoposide
Indication: Product Used FOR Unknown Indication
Revlimid
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: unk
Start date: 2012-05-03
Velcade
Dosage: 1.3 mg, cyclic
Indication: Multiple Myeloma
Start date: 2012-03-07
End date: 2012-04-23
Other drugs received by patient: Metoprolol Succinate; Ramipril; Duloxetime Hydrochloride; Glucophage; Catapres / 00171101 /; Allopurinol; Cymbalta; Percocet; Zometa; Ativan; Ascriptin A / D
Possible Velcade side effects in
Reported by a physician from Spain on 2012-06-29
Patient:
Reactions: Death, Acute Febrile Neutrophilic Dermatosis, Multiple Myeloma
Adverse event resulted in: death
Drug(s) suspected as cause:
Prednisone
Dosage: 0.5 mg/kg, qd
Indication: Prophylaxis
Velcade
Dosage: unk
Indication: Multiple Myeloma
Other drugs received by patient: Prednisone; Omeprazole
Possible Velcade side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-29
Patient: 55 year old male, weighing 71.4 kg (157.1 pounds)
Reactions: Diarrhoea, Drug Ineffective, Neoplasm Progression, Multiple Myeloma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 160 gm;qm;po ; 160 mg;qm;po
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-10-18
End date: 2010-11-09
Dexamethasone
Dosage: 160 gm;qm;po ; 160 mg;qm;po
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Doxorubicin HCL
Dosage: 64 mg;qm;iv ; 64 mg;qm;iv
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Doxorubicin HCL
Dosage: 64 mg;qm;iv ; 64 mg;qm;iv
Indication: Multiple Myeloma
Start date: 2010-10-18
End date: 2010-11-09
Velcade
Dosage: iv ; iv
Indication: Multiple Myeloma
Start date: 2010-09-27
Velcade
Dosage: iv ; iv
Indication: Multiple Myeloma
Start date: 2010-10-18
End date: 2010-11-10
Other drugs received by patient: Enoxaparin Sodium; Gabapentin; Amoxicillin; Acetaminophen
Possible Velcade side effects in
Reported by a pharmacist from United Kingdom on 2012-06-25
Patient:
Reactions: Renal Failure, Drug Ineffective, Multiple Myeloma
Adverse event resulted in: death
Drug(s) suspected as cause:
Velcade
Possible Velcade side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-21
Patient: 55 year old male, weighing 71.0 kg (156.2 pounds)
Reactions: Drug Ineffective, Diarrhoea, Multiple Myeloma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Decadron
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-11-09
Doxorubicin HCL
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-11-09
Velcade
Indication: Multiple Myeloma
Start date: 2010-10-18
End date: 2010-11-10
Velcade
Start date: 2010-09-27
Other drugs received by patient: Amoxicillin; Acetaminophen; Gabapentin; Enoxaparin Sodium
Possible Velcade side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-21
Patient: female, weighing 59.1 kg (130.1 pounds)
Reactions: Hypokinesia, Neuropathy Peripheral, Endotracheal Intubation, Multiple Myeloma
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Aspirin; Lasix; Melatonin; Prilosec; Neurontin; Multi-Vitamins; Sandoz Ciprofloxacin; Zoloft; Potassium Acetate; Probiotic Femina; Niaspan; Buspirone HCL; Fish OIL; Atenolol; Gaviscon
Possible Velcade side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-21
Patient: 55 year old male, weighing 71.4 kg (157.1 pounds)
Reactions: Diarrhoea, Drug Ineffective, Multiple Myeloma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone Sodium Posphate
Dosage: 160 mg, qmo
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Dexamethasone Sodium Posphate
Dosage: 160 mg, qmo
Administration route: Oral
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin HCL
Dosage: 64 mg, qmo
Start date: 2010-10-18
End date: 2010-11-10
Doxorubicin HCL
Dosage: 64 mg/h, qmo
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Velcade
Start date: 2010-10-18
End date: 2010-11-10
Velcade
Indication: Multiple Myeloma
Start date: 2010-09-27
Other drugs received by patient: Amoxicillin; Acetaminophen; Enoxaparin Sodium; Gabapentin
Possible Velcade side effects in
Reported by a physician from Germany on 2012-06-21
Patient:
Reactions: Neoplasm Malignant, Myelodysplastic Syndrome, Multiple Myeloma
Adverse event resulted in: death
Drug(s) suspected as cause:
Lenalidomide
Indication: Myelodysplastic Syndrome
Lenalidomide
Indication: Multiple Myeloma
Melphalan Hydrochloride
Dosage: 200 mg/m2, cyclic
Indication: Multiple Myeloma
Melphalan Hydrochloride
Indication: Myelodysplastic Syndrome
Thalidomide
Indication: Myelodysplastic Syndrome
Thalidomide
Indication: Multiple Myeloma
Velcade
Indication: Multiple Myeloma
Velcade
Indication: Myelodysplastic Syndrome
Possible Velcade side effects in 38 year old male
Reported by a physician from Spain on 2012-06-19
Patient: 38 year old male
Reactions: Tumour Lysis Syndrome, Multiple Myeloma, Influenza
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cisplatin
Indication: Multiple Myeloma
Start date: 2009-09-02
Cyclophosphamide
Indication: Multiple Myeloma
Start date: 2009-09-02
Dexamethasone
Dosage: 4 mg, oral;
Indication: Multiple Myeloma
Start date: 2009-07-03
End date: 2009-08-29
Dexamethasone
Dosage: 4 mg, oral;
Indication: Multiple Myeloma
Start date: 2009-09-02
Etoposide
Start date: 2009-09-02
Velcade
Dosage: 2.7 mg, intravenous
Indication: Multiple Myeloma
Start date: 2009-07-03
End date: 2009-08-29
Other drugs received by patient: Caelyx (Doxorubicin) Injection
Possible Velcade side effects in male
Reported by a physician from Spain on 2012-06-11
Patient: male
Reactions: Tumour Lysis Syndrome, Multiple Myeloma, Influenza
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: taken on 4 days of each cycle
Administration route: Oral
Start date: 2009-07-03
End date: 2009-08-29
Dexamethasone
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-09-02
Doxorubicin HCL
Indication: Multiple Myeloma
Start date: 2009-07-03
End date: 2009-08-29
Velcade
Dosage: administered for 3 days per cycle
Indication: Multiple Myeloma
Start date: 2009-07-03
End date: 2009-08-29
Possible Velcade side effects in
Reported by a consumer/non-health professional from Japan on 2012-06-04
Patient:
Reactions: Rectal Cancer, Platelet Count Decreased, Multiple Myeloma
Adverse event resulted in: death
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Aspirin; Decadron; Onealfa; Calcium Carbonate; Lantus; Lansoprazole; Valtrex; Novorapid
Possible Velcade side effects in female
Reported by a physician from United States on 2012-06-01
Patient: female
Reactions: Mucosal Inflammation, Dysphagia, Periodontal Infection, Neoplasm Progression, Multiple Myeloma, Septic Shock, Renal Failure Chronic
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Dexamethasone
Indication: Multiple Myeloma
Dexamethasone
Indication: Plasmacytoma
Doxorubicin HCL
Indication: Multiple Myeloma
Start date: 2011-04-21
Doxorubicin HCL
Indication: Plasmacytoma
Start date: 2011-04-21
Velcade
Indication: Multiple Myeloma
Start date: 2011-04-21
Velcade
Indication: Plasmacytoma
Start date: 2011-04-21
Possible Velcade side effects in
Reported by a consumer/non-health professional from United States on 2012-05-30
Patient:
Reactions: Multiple Myeloma, Epistaxis
Adverse event resulted in: death
Drug(s) suspected as cause:
Velcade
Page 1 Next >>
|